Just 5.9% of American middle and high school students now vape, a big drop from the 7.7% who did so a year ago, new government data shows. Put another way, about 1.6 million youth now say they used e-cigarettes at least once over the past month, compared to 2.1 million in 2023. Among those who say they vape, 23.6% said they do it on a daily basis. It was high school kids who drove the change, according to the National Youth Tobacco Survey (NYTS), with middle schoolers still vaping at rates roughly similar to a year ago. Still, any reduction in vaping is welcome, said Brian King, director of the U.S. Food and Drug Administration’s Center for Tobacco Products. “The continued decline in e-cigarette use among our nation’s youth is a monumental public health win,” King said in an agency news release. Yolanda Richardson, president of the Campaign for Tobacco-Free Kids, agreed that the new numbers are encouraging, but warned that the vaping and tobacco industry isn’t through with the nation’s kids yet. “Youth e-cigarette use has fallen sharply, sparing many young people from the severe nicotine addiction and other health consequences that can result from e-cigarette use,” she said in a statement. “Despite this progress, youth e-cigarette use remains a serious public health problem in the United States, and the industry remains relentless in…  read on >  read on >

The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. Following a request from the U.S. Food and Drug Administration in July, the DEA said Thursday that Takeda Pharmaceuticals may now increase its production limit by 24%. “These adjustments are necessary to ensure that the United States has an adequate and uninterrupted supply of lisdexamfetamine [Vyvanse] to meet legitimate patient needs both domestically and globally,” the DEA said in a notice it posted on the approval. ADHD drugs have been in short supply for years. The FDA first warned of a shortage of Teva Pharmaceutical Industries’ Adderall medication in October 2022, as the company was plagued by manufacturing delays. That prompted a spike in demand and subsequent shortage of Takeda’s Vyvanse. Why was the DEA’s approval to boost production needed? Vyvanse (lisdexamfetamine) is classified by the DEA as a schedule II controlled substance, which is applied to drugs considered to have a high likelihood of being abused, so additional prescribing safeguards are put in place. The production limit for lisdexamfetamine was increased by 13, 478 pounds (6,236 kilograms), which includes 3,434 pounds (1,558 kg) to address domestic demand and 10,313 pounds (4,678 kg) for foreign demand for finished dosage medications, according to the DEA. After Takeda lost exclusivity…  read on >  read on >

The stereotype of the slacker stoner might not be too far off the mark, a new study shows. People who use weed are prone to workplace absenteeism — and the more problematic the cannabis use, the more likely they are to skip work, results showed. “These findings underscore the importance of developing and implementing strategies to monitor, screen and intervene with individuals at risk for problematic cannabis use,” concluded the research team led by Dr. Kevin Yang, a psychiatric resident with the University of California, San Diego. “To address these issues, workplace prevention programs focusing on education, screening and access to treatment are imperative,” the team said in the paper, which was published recently in the American Journal of Preventive Medicine. For the study, researchers analyzed data on nearly 46,500 people gathered in 2021 and 2022 as part of the National Survey on Drug Use. Nearly 16% of full-time employed adults in the survey said they’d used weed in the past month, and almost 7% appeared to have cannabis use disorder, researchers found. People were more likely to skip work if they’d used weed in the past moth, results showed. Those who used the drug once or twice were 57% more likely to skip work than non-users, while those who used 20 to 30 days were 83% more likely to shrug off their work responsibilities,…  read on >  read on >

Ketamine is becoming a popular depression drug, but doctors aren’t keeping in mind the danger it can pose to a pregnancy, a new study warns. Ketamine can be very harmful to a developing fetus and should not be used during pregnancy, researchers said. But only 20% of ketamine clinics require a pregnancy test at least once prior to or during treatment, according to results published recently in the Journal of Clinical Psychiatry. Further, only 26% of clinics discuss the potential need for contraception with ketamine patients, and fewer than 15% specifically recommend or require contraception use during ketamine treatment, researchers found. That is concerning because more than 80% of clinics prescribe long-term maintenance ketamine, with nearly 70% saying patients receive care for more than six months. “These data suggest that a large population of patients could be pregnant, or could become pregnant, while receiving ketamine treatment,” said lead researcher Dr. Rachel Pacilio, a clinical assistant professor of psychiatry at the University of Michigan.  “Many patients do not know that they’re pregnant in the first weeks, and animal studies of ketamine are very concerning for potential harm to the fetus during this time,” Pacilio added in a university news release. Ketamine is administered to people with depression as an IV drip or through a nasal spray. It works differently from standard antidepressants, according to the Mayo Clinic,…  read on >  read on >

People who can cope with challenges as they grow older are more likely to live longer, a new study shows. Seniors with higher levels of mental resilience are 53% less likely to die within the next 10 years than those with the lowest levels, researchers found. Even with chronic health problems or an unhealthy lifestyle, people with high mental resilience remained 46% and 38% less likely to die within 10 years than those with the least fortitude. “Resilience is often discussed in terms of protective factors, allowing adults in normal environments to maintain relative stability even in the face of highly disruptive events,” wrote the research team led by Dr. Yiqiang Zhan, an associate professor of epidemiology with the Sun Yat-Sen University School of Public Health in China. “This study is unique in establishing a statistically significant association between psychological resilience and all-cause mortality in the older and retired population, even after accounting for confounding factors,” the researchers concluded in a university news release. Good coping skills can help offset long-term chronic illnesses or disabilities in older age, they added. However, it hasn’t been clear whether the ability to cope and adapt is associated with slower aging or a lower risk of death, researchers said. To examine this, they analyzed data from more than 10,500 participants in a U.S. health and retirement study involving people 50…  read on >  read on >

Your cellphone might be harming your heart, a new study warns. People who regularly use a cellphone have a higher risk of heart disease, researchers found in a large-scale study. And the more time someone spends on their phone, the greater their risk for heart problems, researchers report. Risk of heart disease was about 21% higher in people who use their phone six hours or more a week, compared with 15% higher for those on the phone four to six hours and 13% for one to three hours, results show. “We found that compared with non-regular mobile phone users, regular mobile phone users had a significantly higher risk of incident cardiovascular diseases,” said researcher Dr. Ziliang Ye, with Southern Medical University in China. For the study, researchers analyzed data from more than 444,000 participants in the long-term UK Biobank research project. The participants all reported the frequency of their cellphone use. Researchers defined regular mobile phone use as at least one call per week. The research team tracked the participants for about 12 years, looking to see if they’d been diagnosed with stroke, heart disease, heart rhythm problems or heart failure. It turned out that regular phone users did have a higher risk of heart problems, compared to non-users, and that more cellphone use increased that risk. Cellphone use can impact a person’s sleep patterns…  read on >  read on >

The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects from taking Ozempic or Wegovy. But a new study rules out one possible problem — using semaglutide does not increase a person’s risk of depression or suicide, researchers report. Semaglutide did not increase the risk of depression, suicidal thoughts or suicidal behavior in people without known mental health disorders, according to an analysis of data from clinical trials that led to approval of the drug. The new study reviewed data from more than 3,500 people across four major clinical trials for semaglutide. The trials were funded by Novo Nordisk, the maker of Ozempic and Wegovy. About 1% or fewer of the clinical trial participants reported suicidal thoughts or behaviors, with no differences between those taking semaglutide or a placebo, researchers reported Sept. 3 in the journal JAMA Internal Medicine. What’s more, 2.8% of those taking semaglutide developed depressive symptoms, compared with 4.1% of those taking a placebo. “It is certainly possible that individuals with overweight or obesity who take semaglutide may experience depressive symptoms or suicidal ideation or behavior, but the data suggest that persons not taking semaglutide — in the placebo group in this study — are equally likely to experience these conditions,” said researcher Gregory Brown, director of the Penn Center for the Prevention of Suicide at…  read on >  read on >

A survey of Australian adolescents finds those who are experiencing depressive symptoms have double the risk of taking up vaping. “In the short term, nicotine may reduce feelings of anxiety and stress, and young people may be reaching for vapes as a coping mechanism,” said study co-author Emily Stockings. “Regardless of whether mental ill health influences smoking or vice-versa, it is clear that if we are to prevent vaping onset, we need to address mental health at the same time,” said Stockings, who is an associate professor of medicine at the University of Sydney’s Matilda Center. Her team published its findings Sept. 2 in the Australian & New Zealand Journal of Psychiatry. The study tracked the mental health and vaping rates of more than 5,000 Year 7 and 8 students (about 12-13 years of age) from 40 schools in New South Wales, Queensland and Western Australia. About 8.3% said they’d used e-cigarettes. Compared to kids with low stress levels, those who said they had moderate levels of stress were 74% more likely to have taken up vaping, and those who said they had high stress levels were 64% more likely to vape, the study found. Vaping was 105% more likely among adolescents who rated their well-being as low versus though who said it was high. There was no link between anxiety levels and adolescent vaping,…  read on >  read on >

A new, tougher rule on the sale of tobacco products will require retailers to check the IDs of any buyers under the age of 30, the U.S. Food and Drug Administration announced Thursday. The final rule, which will go into effect Sept. 30, also restricts tobacco vending machine sales to spaces that are limited to people aged 21 and older. “Today’s rule is another key step towards protecting our nation’s youth from the health risks of tobacco products,” Dr. Brian King, head of the FDA’s Center for Tobacco Products, said in an agency news release on the rule. “Decades of science has shown that keeping tobacco products away from youth is critical to reducing the number of people who ultimately become addicted to these products and suffer from tobacco-related disease and death.” Importantly, the new restrictions also apply to e-cigarettes, which are popular among young smokers. Although the number of children using e-cigarettes has started to decline over the past five years, 1 out of 10 high schoolers still say they vaped in the previous 30 days. For middle schoolers, that number was 1 in 22, according to the U.S. Centers for Disease Control and Prevention. Studies also show that 9 out of 10 adults who smoke daily reported having their first cigarette by age 18, CNN reported. The federal age limit for tobacco purchases was 18 until…  read on >  read on >

Teaching schoolkids to practice mindfulness can boost their mental health — and, maybe, even their grades. That’s the takeaway from a new review of more than three dozen research studies on school-based mindfulness interventions, such as seated or slow-walking meditation.  In a nutshell, these programs teach kids to pay attention to the present moment and not to be judgmental about it.  “As mindfulness interventions become more widely used and extensively studied, they hold promise for fostering student well-being and mitigating the development of mental health conditions over time,” Tina Marshall and her colleagues at the Maryland research organization Westat wrote in the journal Psychiatry Online. Her team reviewed 41 studies published between 2008 and 2022 of school-based mindfulness interventions. All had at least two mindfulness components — for example, a combo of breathing awareness and awareness of body sensations. Of 24 interventions researchers identified, three had strong evidence of effectiveness: Learning to BREATHE  Mindfulness in School Project (MiSP) Mindfulness-based stress reduction (MBSR) All three included such components as awareness of breathing, bodily sensations, mental states and regulating one’s own emotions. Participants in these studies were middle and high school students. Three other interventions — Gaia Program, MindUP and a program that combined MBSR with mindfulness cognitive therapy — were also shown to be somewhat helpful in the elementary school children studied. These interventions generally promoted…  read on >  read on >